Dabigatran etexilate Completed Phase 1 Trials for Cardiovascular Disease (CVD) / Chronic Renal Failure (CRF)

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT01241539Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis